Author:
Mandal Snigdha Das,Mandal Surjyanarayan,Patel Devanshu
Publisher
Springer Nature Switzerland
Reference57 articles.
1. Witzmann FA, Grant RA. Pharmacoproteomics in drug development. Pharmacogenomics J. 2003;3:69–76.
2. Prasad B, Vrana M, Mehrotra A. The promises of quantitative proteomics in precision medicine. J Pharm Pharm Sci. 2017;106:738–44.
3. Rebecca CP, Zhaoxiang C, Phillip JR, et al. Opportunities for pharmacoproteomics in biomarker discovery. Proteomics. 2023;23:7–8.
4. Nandal S, Burt T. Integrating pharmacoproteomics into early-phase clinical development: state-of-the-art, challenges, and recommendations. Int J Mol Sci. 2017;18:448–56.
5. Ideker T, Thorsson V, Ranish JA, et al. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science. 2001;292:929–34.